Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2010 Apr;17(4):950-2.
doi: 10.1245/s10434-009-0859-9.

Challenges in the study of adjuvant chemoradiation after pancreaticoduodenectomy

Editorial

Challenges in the study of adjuvant chemoradiation after pancreaticoduodenectomy

Christopher H Crane et al. Ann Surg Oncol. 2010 Apr.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

Cited by

References

    1. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the Pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567–79. - PubMed
    1. Takai S, Satoi S, Toyokawa H, et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas. 2003;26:243–9. - PubMed
    1. Richter A, Niedergethmann M, Sturm JW, et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003;27:324–9. - PubMed
    1. Regine W, Winter K, Abrams R, et al. RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. J Clin Oncol. 2006;24:4007.
    1. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–10. - PubMed